methoxamine has been researched along with Atherogenesis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernhardt, F; Bertin, F; Félétou, M; Levy, BI; Michel, F; Paysant, J; Sansilvestri-Morel, P; Silvestre, JS; Simonet, S; Vayssettes-Courchay, C; Verbeuren, TJ | 1 |
1 other study(ies) available for methoxamine and Atherogenesis
Article | Year |
---|---|
Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Apolipoproteins E; Atherosclerosis; Diabetes Mellitus, Experimental; Dinoprost; Disease Models, Animal; Epoprostenol; Kidney; Male; Methoxamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalenes; Propionates; Receptors, Thromboxane A2, Prostaglandin H2; Streptozocin; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2008 |